Can a new eye drop help contact lens wearers beat dry eye?

NCT ID NCT07054606

Completed Symptom relief Sponsor: Bausch & Lomb Incorporated Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether Miebo eye drops (perfluorohexyloctane) can safely and effectively relieve dry eye symptoms in people who wear soft contact lenses. 104 adults used the drops up to four times daily, both before and while wearing their lenses. Researchers measured changes in dry eye symptoms using a standard questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: perfluorohexyloctane eye drops (Miebo)
What this could lead to: If it works, this could offer a new option for contact lens users to manage dry eye symptoms without removing their lenses.
What could go wrong: This is a small, completed Phase 4 trial with only 104 participants. Results may not apply to everyone, and the drops might not work for all types of dry eye.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE

Contacts and locations

Locations

Site 101

San Diego, California, 92307, United States
Site 102

Medina, Minnesota, 55340, United States
Site 103

Athens, Ohio, 45701, United States
Site 104

Pittsburg, Kansas, 66762, United States
Site 107

Longwood, Florida, 32779, United States
Site 108

Vestal, New York, 13850, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.